Clinical Guest Contributors
-
Understanding Precision Neuroscience As Treatment For Rare Autoantibody Disease
1/19/2024
J&J Innovative Medicine develops precision therapeutics in neuroscience, reducing the trial participation and treatment burdens on people living with generalized myasthenia gravis.
-
Balancing TMF Management After A Mass Layoff
1/16/2024
Discover nine next steps for you and your TMF team to help address the uncertainty of layoffs and maintain an accurate and up-to-date trial master file.
-
Patient Engagement Needs More Benefit Analysis, Fewer Theoretical Conversations
1/12/2024
Are companies just tagging on to the status quo of being “patient-centric” without fully analyzing the return on investment for their company? Consultant and patient advocate Ella Balasa discusses.
-
Why — And How — To Improve Adherence To Treatment In Clinical Trials
1/12/2024
In part two of this series, discover the benefits of adherence to treatment, as well as immediate ways to leverage current services, tools, and resources to improve patient adherence.
-
Understanding The Effects Of Non-Adherence To Treatment In Clinical Trials
1/11/2024
In part one of this series, discover the severity of the patient nonadherence in clinical trials and understand the conditions that contribute to nonadherence to treatment.
-
Why We Need More Women In Clinical Research — Now
1/10/2024
Society’s tendency to view the male body as “default” has had relatively benign, if not uncomfortable, effects. But, gender bias can have serious consequences, including in clinical research.
-
Enhancing Clinical Trial Efficiency & Compliance With eQMS
1/10/2024
In recent years, electronic quality management systems (eQMS) have emerged as powerful tools to streamline and enhance the quality control processes in clinical trials. This article explores the key components, benefits, challenges, and future of eQMS in the context of clinical trials.
-
What Rare Disease Patients Want Sponsors To Know
1/9/2024
A rare disease caregiver and patient, Sabina Kineen hopes to shine a light on the importance of clinical trial education for patients and caregivers and how sponsors can support them.
-
The 3 Big Downsides To DCTs
1/8/2024
James Gillespie, Ph.D., and Gregory Privitera, Ph.D. discuss three overlapping categories of concern when it comes to DCTs: consent and selection, user experience, and comfort and privacy.
-
AI In Drug Discovery And Development — Will It Live Up To The Hype?
1/5/2024
While AI may soon transform the drug discovery and development process, there are still several barriers, both technical and ethical, to the rise of AI in biopharma.